Pepticore Aminos si riserva il diritto di rifiutare la vendita a qualsiasi individuo o ente sospettato di uso improprio dei propri prodotti
Iqbal, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
doi:10.4049/jimmunol.181.3.2103 2019 The Author(s)
A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo
From sports injuries to post-surgical recovery, discover how this innovative approach can optimize healing and restore health efficiently
Musculoskeletal injury and repair Gastrointestinal mucosal healing Neuroprotection and neural recovery Wound healing and tissue regeneration Anti-inflammatory modulation Key Findings from the Literature 01Consistent tendon, ligament, and bone repair improvements in animal models 022025 pilot human IV study demonstrated safety at 1020mg doses 03FDA Category 2 bulk drug substance active area of clinical investigation 04Upregulates GH receptor density in fibroblasts without altering systemic hormone levels 1 Independent third-party lab reports for this peptide